In an important minority of hypertensive patients, hypertension is secondary to an identifiable primary condition. Failure to consider secondary hypertension may result in failure to diagnose and treat harmful or life-threatening primary causes, and also ineffective blood pressure management. This article reviews the main causes of secondary hypertension, with an emphasis on their clinical clues and whom to investigate, along with their management options.
Get full access to this article
View all access options for this article.
References
1.
WilliamsB, PoulterNR, BrownMJ, Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens2004; 18: 139–85
PacakK, EisenhoferG, AhlmanH, Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nature Clin Pract Endocrinol Metab2007; 3: 92–102
4.
BoyleJG, DavidsonDF, PerryCG, ConnellJMC. Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma. J Clin Endocrinol Metab2007; 92: 4602–8
5.
De JongWHA, EisenhoferG, PostWJ, MuskietFAJ, de VriesEGE, KemaIP.Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors. J Clin Endocrinol Metab2009; 94: 2841–9
6.
CarrJA.The results of catheter-based therapy compared with surgical repair of adult aortic coarctation. J Am Coll Cardiol2006; 47: 1101–7
7.
SlovutDP, OlinJW.Fibromuscular dysplasia. N Eng J Med2004; 350: 1862–71
8.
HansenKJ, EdwardsMS, CravenTE, Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg2002; 36: 443–51
9.
ConlonPJ, AthirakulK, KovalikE, Survival in renal vascular disease. J Am Soc Nephrol1998; 9: 252–6
10.
MetcalfeW, ReidAW, GeddesCC.Prevalence of angiographic atherosclerotic renal artery disease and its relationship to the anatomical extent of peripheral vascular atherosclerosis. Nephrol Dial Transplant1999; 14: 105–8
11.
HirschAT, HaskalZJ, HertzerNR, ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. J Am Coll Cardiol2006; 47: 1239–312
12.
IvesNJ, WheatleyK, StoweRL, Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant2003; 18: 298–304
13.
ASTRAL investigators. Revascularization versus medical therapy for renal artery stenosis. N Eng J Med2009; 361: 1953–62
14.
FunderJW, CareyRM, FardellaC, Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab2008; 93: 3266–81
15.
RossiGP, BerniniG, CaliumiC, A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol2006; 48: 2293–300
16.
NiemanLK, BillerBMK, FindlingJW, The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab2008; 93: 1526–40
17.
PopeJE, AndersonJJ, FelsonDT.A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med1993; 153: 477–84
18.
LangrishJP, MillsNL, BathLE, Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension2009; 53: 805–11
GranthamJJ.Autosomal dominant polycystic kidney disease. N Eng J Med2008; 359: 1477–85
21.
AlajmiM, MulgrewAT, FoxJ, Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung2007; 185: 67–72
